Related Experiment Video
Updated: Jun 2, 2026

Systematic Bronchoscopy: the Four Landmarks Approach
Published on: June 23, 2023
Airway clearance management for bronchiectasis in China: a multicentre cross-sectional study from the Chinese
Yang Liu1,2, Yi-Fan Wu1,2,3, Yuan-Lin Song4
1Department of Respiratory and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Background:
Airway clearance techniques (ACTs) are guideline-recommended in bronchiectasis, while contemporary patterns and determinants of ACTs adoption remain unclear in China.
Methods:
A multicentre cross-sectional study was conducted using data from the BE-China cohort between 10 Jan 2020 and 31 Mar 2024. Clinical characteristics and prespecified ACT modalities were collected across 92 hospitals. Multivariable logistic regression identified important associations of ACTs utilization.
Findings:
Among 9647 patients, 12.2% (1177) used regular ACTs at baseline, and regional heterogeneity in ACTs utilization was observed. Moreover, ACTs users exhibited prolonged disease duration, a higher proportion of severe disease, greater comorbidity, heavier cough and sputum burden, and more frequent pharmacological and ventilatory interventions. Variables associated with increased ACTs utilization included comorbid burden (OR 1.47, 1.28-1.70; p < 0.0001), daily sputum (OR 1.68, 1.33-2.10; p < 0.0001), expectorants usage (OR 3.19, 2.74-3.71; p < 0.0001), inhaled antibiotics (OR 2.04, 1.35-3.07; p = 0.00065), macrolide therapy (OR 2.31, 1.78-2.99; p < 0.0001), other long-term oral antibiotics (OR 1.37, 1.13-1.66; p = 0.0013), noninvasive ventilation requirement (OR 4.11, 3.14-5.39; p < 0.0001), and disease duration (per SD increase, OR 1.08, 1.01-1.15; p = 0.027). Both BE-China and the similar European Bronchiectasis Registry (EMBARC) cohorts showed distinct etiological and comorbidity profiles, yet consistently revealed a higher medication burden among ACTs users.
Interpretation:
In China, ACTs utilization is primarily concentrated among patients with bronchiectasis who have a heavier symptom burden and greater treatment intensity. Clinicians may leverage the identified associations to optimize adherence and guide phenotype-targeted ACTs implementation strategies, and these findings may serve as a reference for future research.
Funding:
Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission, Program of Shanghai Municipal Science and Technology Commission, Major Project of Guangzhou National Laboratory.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Management Using Bronchodilators and Corticosteroids
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...